DK389375A - - Google Patents

Info

Publication number
DK389375A
DK389375A DK389375A DK389375A DK389375A DK 389375 A DK389375 A DK 389375A DK 389375 A DK389375 A DK 389375A DK 389375 A DK389375 A DK 389375A DK 389375 A DK389375 A DK 389375A
Authority
DK
Denmark
Application number
DK389375A
Other languages
Danish (da)
Other versions
DK136075C (US07652168-20100126-C00068.png
DK136075B (da
Inventor
G H Phillipps
M D Bain
J C Clark
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DK389375A publication Critical patent/DK389375A/da
Publication of DK136075B publication Critical patent/DK136075B/da
Application granted granted Critical
Publication of DK136075C publication Critical patent/DK136075C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK389375AA 1974-08-30 1975-08-29 Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater. DK136075B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38089/74A GB1517278A (en) 1974-08-30 1974-08-30 Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates

Publications (3)

Publication Number Publication Date
DK389375A true DK389375A (US07652168-20100126-C00068.png) 1976-03-01
DK136075B DK136075B (da) 1977-08-08
DK136075C DK136075C (US07652168-20100126-C00068.png) 1978-01-09

Family

ID=10401103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK389375AA DK136075B (da) 1974-08-30 1975-08-29 Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater.

Country Status (12)

Country Link
US (1) US3981894A (US07652168-20100126-C00068.png)
JP (1) JPS5148648A (US07652168-20100126-C00068.png)
BE (1) BE832888A (US07652168-20100126-C00068.png)
CH (1) CH612687A5 (US07652168-20100126-C00068.png)
DE (1) DE2538627A1 (US07652168-20100126-C00068.png)
DK (1) DK136075B (US07652168-20100126-C00068.png)
FR (1) FR2282898A1 (US07652168-20100126-C00068.png)
GB (1) GB1517278A (US07652168-20100126-C00068.png)
IE (1) IE41662B1 (US07652168-20100126-C00068.png)
NL (1) NL7510225A (US07652168-20100126-C00068.png)
SE (1) SE411904B (US07652168-20100126-C00068.png)
ZA (1) ZA755554B (US07652168-20100126-C00068.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3002746A1 (de) * 1980-01-23 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin 1-hydroxysteroide, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
BRPI0113042B8 (pt) 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
BR0209271A (pt) * 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof

Also Published As

Publication number Publication date
IE41662L (en) 1976-02-29
BE832888A (fr) 1976-03-01
DK136075C (US07652168-20100126-C00068.png) 1978-01-09
DK136075B (da) 1977-08-08
IE41662B1 (en) 1980-02-27
SE411904B (sv) 1980-02-11
AU8440375A (en) 1977-03-03
DE2538627A1 (de) 1976-03-11
JPS5148648A (US07652168-20100126-C00068.png) 1976-04-26
CH612687A5 (US07652168-20100126-C00068.png) 1979-08-15
GB1517278A (en) 1978-07-12
FR2282898B1 (US07652168-20100126-C00068.png) 1978-11-10
SE7509650L (sv) 1976-03-01
ZA755554B (en) 1976-08-25
NL7510225A (nl) 1976-03-02
US3981894A (en) 1976-09-21
FR2282898A1 (fr) 1976-03-26

Similar Documents

Publication Publication Date Title
FR2264662B1 (US07652168-20100126-C00068.png)
FR2282898B1 (US07652168-20100126-C00068.png)
DK10375A (US07652168-20100126-C00068.png)
FR2288638B1 (US07652168-20100126-C00068.png)
FR2284838B1 (US07652168-20100126-C00068.png)
FR2259543B1 (US07652168-20100126-C00068.png)
JPS50101430A (US07652168-20100126-C00068.png)
AU495920B2 (US07652168-20100126-C00068.png)
FR2292871B1 (US07652168-20100126-C00068.png)
AU7099174A (US07652168-20100126-C00068.png)
AU7138274A (US07652168-20100126-C00068.png)
CS175097B1 (US07652168-20100126-C00068.png)
CS169250B1 (US07652168-20100126-C00068.png)
AU481044A (US07652168-20100126-C00068.png)
BG19982A1 (US07652168-20100126-C00068.png)
AU482019A (US07652168-20100126-C00068.png)
AU481580A (US07652168-20100126-C00068.png)
AU481457A (US07652168-20100126-C00068.png)
AU481340A (US07652168-20100126-C00068.png)
AU481101A (US07652168-20100126-C00068.png)
AU481082A (US07652168-20100126-C00068.png)
BG20001A1 (US07652168-20100126-C00068.png)
AU480580A (US07652168-20100126-C00068.png)
AU480469A (US07652168-20100126-C00068.png)
AU480209A (US07652168-20100126-C00068.png)